Ariella, originally from England, advises local and international entrepreneurs, private and public companies, start-ups, corporate ventures, private equity and venture capital funds.
Ariella’s clients engaged in a wide range of high tech activities, including, life sciences, medical devices, digital health, mobility, blockchain, IOT, financial services, cyber security, as well as low-tech industries.
Ariella skilfully guides her clients in drafting and negotiating multi-layered corporate and commercial agreements, including establishing strategic partnerships, raising capital, complex cross-border mergers and share and asset acquisitions, as well as distribution, franchise, licensing and manufacturing agreements – all the while considering each client’s unique commercial concerns.
Ariella also has extensive experience in advising on healthcare matters, including clinical trials, regulatory issues (data protection, registration, reimbursement and licenses) and manufacturing, distribution, licensing and supply agreements.
Prior to joining Barnea, she served as a research assistant to Professor Daphne Barak-Erez (current Supreme Court Justice) and as a foreign clerk to former Supreme Court President Dorit Beinisch.
Prominent legal directories regularly rank Ariella as a leading lawyer in her fields of activity. In 2022, The Legal 500 ranked Ariella as a Next Generation Partner in the Mergers & Acquisitions practice area. The Legal 500 also ranked her as a Recommended Lawyer in the Hi-Tech & Start-Ups practice area. In addition, IFLR1000 has ranked Ariella as a leading attorney in Mergers & Acquisitions for several straight years.
University of Birmingham, England LL.B. Hons. 2005
Member of Israel Bar Association since 2008
News and updates - Ariella Dreyfuss:
Migdal Group invests in Scandinavian energy
Migdal Group has invested, together with other partnerships, in the alternative energy projects of Fu-Gen AG and Fu-Gen Assets 4 AB. Firm partners Micky Barnea, Ariella Dreyfuss, and Roy Engel advised on the NIS 1 billion investment.
Warburg Pincus Leads Funding Round in Israeli Digital Health Startup MDClone
We were delighted to represent the global private equity firm Warburg Pincus in its investment in the Israeli Healthcare Data Analysis company MDClone.
Advs. Ariella Dreyfuss, Tal Freilich and Anat Even-Chen advised on this transaction.
Shift 4 Acquires Israeli Clearing Technology Company Finaro
Shift4 Payments, an American public company, has acquired Finaro for a value of USD 575 million.
Advs. Simon Jaffa, Ariella Dreyfuss, Mayer Winkler, Harel Perlmutter, Hanna Daher, Sandra Guzelbahar, and Fadi Atallah advised on the transaction.